AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Remer, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remer, T.
Agricola
Right arrow Articles by Remer, T.
American Journal of Clinical Nutrition, Vol. 87, No. 1, 192-193, January 2008
© 2008 American Society for Nutrition


LETTER TO THE EDITOR

Dietary calcium, the 16{alpha}-hydroxyl metabolic pathway of steroids, and sex hormones in blood and urine

Thomas Remer

Department of Nutrition and Health
Research Institute of Child Nutrition
Heinstück 11
Dortmund 44225
Germany
E-mail: remer{at}fke-do.de

Dear Sir:

In a recent article in the Journal, Napoli et al (1) reported cross-sectional data in healthy postmenopausal white women, which suggested that a higher calcium intake from dietary sources may be associated with a shift in estrogen metabolism toward the active 16{alpha}-hydroxyl metabolic pathway and with greater bone mineral density. This study addresses the important field of steroid hormone metabolomics and underscores that steroid metabolite profiling in 24-h urine specimens allows one to uncover physiologically relevant shifts in hormone metabolism, which is usually not possible with the same physiologic plausibility if only single blood measurements are performed. Accordingly, the serum estradiol measurements made by Napoli et al showed no differences between the 3 diet groups under study.

This closely corresponds to what cross-sectional blood measurements tell us about the developmental process of adrenarche, ie, the period during which the adrenal glands of healthy children begin to secrete increasing amounts of androgenic hormones. The many blood measurements of the major adrenarchal steroid hormone dehydroepiandrosterone (DHEA) and its sulfated form (DHEAS), until recently performed, suggest that adrenarche begins at approximately the age of 6–7 y (2). However, specific steroid profiling in 24-h urine samples in healthy children of the DOrtmund Nutritional and Anthropometric Longitudinally Designed (DONALD) Study showed that the physiologic increase in adrenal androgen secretion must already start several years before midchildhood (3).

As in the study by Napoli et al, these changes were not detectable by measuring only one key hormone [DHEA(S)], but they became unmasked after the major 16{alpha}-hydroxylated downstream metabolites of DHEA, ie, 16{alpha}-hydroxy-DHEA and 3β,16{alpha},17β-androstenetriol, were additionally profiled (3). The 16{alpha}-hydroxylation described by Napoli et al for estrogens in postmenopausal women is also a major metabolic pathway for adrenal androgens, and that pathway obviously lowers the circulating concentrations of the primary adrenal androgen DHEA(S) efficiently in early childhood. Thus, the sole measurement of DHEA(S) in preschool children does not reflect its increasing formation and especially not the rise in its activated 16{alpha}-hydroxylated downstream metabolites occurring after age 3 y (3).

Unfortunately, some relevant aspects of the postmenopausal metabolism of estrogen in women may have been overlooked by Napoli et al.

  1. )Since ovarian steroid hormone secretion decreases more dramatically during aging than adrenal androgen secretion, most of the postmenopausally circulating estrogens originate from adrenal androgen precursors [primarily DHEA(S)] (4). The enzyme aromatase, which is preferentially expressed in adipose tissue and skeletal muscle (5), converts androgens to estrogens and also converts 16{alpha}-hydroxy-DHEA to 16{alpha}-hydroxy-estrone (after a preceding enzymatic 3β-hydroxysteroid dehydrogenase step) (6). Given this strong interaction between the adrenal gland and peripheral estrogen production, the findings of Napoli et al might have been somewhat more specific if they had also excluded from their study those women with glucocorticoid medication use at a dose <5 mg/d of prednisone (or the equivalent). Whether women with a more pronounced adrenarche during childhood and adolescence may also have higher estrogen production after menopause is unknown, but it appears plausible given the high tracking of adrenal androgens (7, 8).
  2. )The summation of major urinary metabolites of estrogens, androgens, or glucocorticoids is an appropriate method to assess the overall production of the respective hormone group. Accordingly, Napoli et al quantified 2 major estrogen metabolites and 2 major estrogen metabolite groups. However, the genuine estrogens estrone and estradiol themselves were not quantified by the authors. Thus, their estimate of total estrogen production might be somewhat biased in the examined diet groups.
  3. )From the nutritional data presented in the article of Napoli et al, it is not clear whether intakes of other nutrients differed between the 3 groups with various calcium intakes. It appears possible that (milk) protein intake was higher in those 2 groups with a dietary calcium intake {approx}2-fold higher. It can thus not be excluded that the higher bone mineral density observed in the latter 2 groups was primarily due to a higher protein intake (9). Additionally, a varying protein intake may have altered the urinary estrogen profile (10). Taken together, it remains questionable whether it is really the calcium that is responsible for the observed shift in estrogen metabolism.

ACKNOWLEDGMENTS

The author had no conflict of interest related to this letter.

REFERENCES

  1. Napoli N, Thompson J, Civitelli R, Armamento-Villareal RC. Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density. Am J Clin Nutr 2007;85:1428–33.[Abstract/Free Full Text]
  2. Havelock JC, Auchus RJ, Rainey WE. The rise in adrenal androgen biosynthesis: adrenarche. Semin Reprod Med 2004;22:337–47.[Medline]
  3. Remer T, Boye KR, Hartmann MF, Wudy SA. Urinary markers of adrenarche: reference values in healthy subjects aged 3–18 years. J Clin Endocrinol Metab 2005;90:2015–21.[Abstract/Free Full Text]
  4. Misso ML, Jang C, Adams J, et al. Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause 2005;12:210–5.[Medline]
  5. Larionov AA, Vasyliev DA, Mason JI, Howie AF, Berstein LM, Miller WR. Aromatase in skeletal muscle. J Steroid Biochem Mol Biol 2003;84:485–92.[Medline]
  6. Schmidt M, Weidler C, Naumann H, Anders S, Scholmerich J, Straub RH. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes—androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. Arthritis Res Ther 2005;7:R938–48.[Medline]
  7. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832–8.[Abstract/Free Full Text]
  8. Remer T, Manz F. Role of nutritional status in the regulation of adrenarche. J Clin Endocrinol Metab 1999;84:3936–44.[Abstract/Free Full Text]
  9. Alexy U, Remer T, Manz F, Neu CM, Schoenau E. Long-term protein intake and dietary potential renal acid load are associated with bone modeling and remodeling at the proximal radius in healthy children. Am J Clin Nutr 2005;82:1107–14.[Abstract/Free Full Text]
  10. Adlercreutz H, Fotsis T, Hockerstedt K, et al. Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Steroid Biochem 1989;34:527–30.[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Remer, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remer, T.
Agricola
Right arrow Articles by Remer, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS